1.98 CNY
184.76 M CNY
930.87 M CNY
35.97 M
About BEIJING SUN-NOVO PHARMACEUTICAL RES
Sector
CEO
Yu Jing Liu
Headquarters
Beijing
Website
Founded
2009
ISIN
CNE100005139
FIGI
BBG00X3X5ZY1
Beijing Sun-Novo Pharmaceutical Research Co., Ltd. engages in the research and development of pharmaceutical products. It mainly focuses on generic and innovative drug research and offers chemical drugs and peptide drugs. The company also provides preclinical and clinical drug development services. Beijing Sun-Novo Pharmaceutical Research was founded on March 9, 2009 and is headquartered in Beijing, China.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 688621 is 46.17 CNY — it has increased by 0.87% in the past 24 hours. Watch BEIJING SUN-NOVO PHARMACEUTICAL RES stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on SSE exchange BEIJING SUN-NOVO PHARMACEUTICAL RES stocks are traded under the ticker 688621.
688621 stock has risen by 18.23% compared to the previous week, the month change is a 32.67% rise, over the last year BEIJING SUN-NOVO PHARMACEUTICAL RES has showed a −26.32% decrease.
688621 reached its all-time high on Oct 8, 2021 with the price of 134.29 CNY, and its all-time low was 28.90 CNY and was reached on Sep 24, 2024. View more price dynamics on 688621 chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
688621 stock is 4.65% volatile and has beta coefficient of 1.66. Track BEIJING SUN-NOVO PHARMACEUTICAL RES stock price on the chart and check out the list of the most volatile stocks — is BEIJING SUN-NOVO PHARMACEUTICAL RES there?
Today BEIJING SUN-NOVO PHARMACEUTICAL RES has the market capitalization of 5.17 B, it has increased by 8.94% over the last week.
Yes, you can track BEIJING SUN-NOVO PHARMACEUTICAL RES financials in yearly and quarterly reports right on TradingView.
688621 net income for the last quarter is 59.12 M CNY, while the quarter before that showed 75.82 M CNY of net income which accounts for −22.03% change. Track more BEIJING SUN-NOVO PHARMACEUTICAL RES financial stats to get the full picture.
Yes, 688621 dividends are paid annually. The last dividend per share was 0.17 CNY. As of today, Dividend Yield (TTM)% is 0.36%. Tracking BEIJING SUN-NOVO PHARMACEUTICAL RES dividends might help you take more informed decisions.
BEIJING SUN-NOVO PHARMACEUTICAL RES dividend yield was 0.24% in 2023, and payout ratio reached 10.00%. The year before the numbers were 0.42% and 21.91% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Feb 22, 2025, the company has 1.37 K employees. See our rating of the largest employees — is BEIJING SUN-NOVO PHARMACEUTICAL RES on this list?
Like other stocks, 688621 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade BEIJING SUN-NOVO PHARMACEUTICAL RES stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So BEIJING SUN-NOVO PHARMACEUTICAL RES technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating BEIJING SUN-NOVO PHARMACEUTICAL RES stock shows the sell signal. See more of BEIJING SUN-NOVO PHARMACEUTICAL RES technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.